biorevert Revenue
Biotechnology Research • 
193 Munji-ro, T211 Truth Hall, Korea, Republic of • 1-10 Employees
$
biorevert revenue & valuation
| Annual revenue | $342,220 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,100,000 |
| Total funding | No funding |
Key Contact at biorevert
Sea Choi
Co-founder & Chief Global Strategist
Company overview
| Headquarters | 193 Munji-ro, T211 Truth Hall, Yuseong-gu, Daejeon 34051, KR |
| Website | |
| NAICS | 541714 |
| Keywords | Target Id, 항암, Reverse Aging, Cancer Reversion, Mechanism Analysis, 노화, 시스템생물학 |
| Founded | 2022 |
| Employees | 1-10 |
About biorevert
We develop reversion therapeutic technologies to revert cancer and aging.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Founder/Owner
Employees by Department
biorevert has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
biorevert has never raised funding before.
Singapore
India
Netherlands
United States
Frequently asked questions
biorevert is located in 193 Munji-ro, T211 Truth Hall, KR.
biorevert generates an estimated annual revenue of $342,220. This revenue figure reflects the company's market position and business performance in its industry.
biorevert has an estimated valuation of $1,100,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
biorevert was founded in 2022, making it 4 years old. The company has established itself as a significant player in its industry over this time.
biorevert has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
